Further functional validation is necessary to clarify the mechanistic interplay between KCa3.1 and its interacting partners, particularly in pathways related to tumor invasion, immune evasion, and drug resistance, and to nail down the specific role of mitochondrial KCa3.1 in cancer‐related processes. The gene discussed is KCNN4; the disease is neoplasm.